Mark Brooks

A civil mortgage fraud lawsuit filed in U.S. District Court in Manhattan on Tuesday seeks to recover hundreds of millions of dollars that the Federal Housing Administration, which insured the loans, had to pay out after borrowers defaulted.

Company's top lobbyist to take new post Jan. 1.

A three-judge panel has already blocked the mandate for graphic labels.

Her visit triggered protests attended by some 50,000 demonstrators in Athens.

Report predicts Japanese auto exports to China will crash 70% in current quarter.

The coal industry has been battered this year by anemic demand for thermal coal, used to generate electricity, and for metallurgical coal, which is used in steel manufacturing.

Gates said he would be happy to offer the U.S. president his advice.

The Bentonville, Ark.-based discounter is trying to cater to Web-savvy shoppers who are demanding more convenience.

International Consolidated Airlines Group has offered to invest in the airline.

Marvel NOW promises "bold new directions."

The problem was caused by a severed Sprint fiber optic line that cut the Seattle-based airline's connection to its Sabre ticketing system at 7:40 a.m.

The dollar rose against most major currencies Monday on fears that the global economy is slowing.

Merkel's brief visit comes amid growing unrest in Greece over the planned new cutbacks.

A strong warning from the World Bank that growth in Asia may slow further dragged the price of oil Monday to its lowest close in two months.

YouTube is extending its original programming initiative into Europe, with at least 60 new video channels from media companies including Britain's BBC, London-based FreemantleMedia, and the Netherlands' Endemol.

Huawei Technologies and ZTE Corp. respond to being singled out.

It is part of a move to bring 90 percent of information technology in-house, which GM believes will make the company more nimble and efficient.

By next summer, Delta plans to operate more than 40 daily flights to 15 destinations from Seattle.

Eli Lilly is developing solanezumab.

Soda giants get a jump on new regulation.